Subtopic Deep Dive
Cardiac Myxomas
Research Guide
What is Cardiac Myxomas?
Cardiac myxomas are the most common primary benign cardiac tumors, typically arising in the left atrium, that can cause life-threatening embolization and obstruction despite their histological benignity.
Cardiac myxomas account for about half of all primary cardiac tumors and predominantly affect women. They often present with symptoms mimicking mitral valve disease or systemic illnesses (Reynen, 1995; 1139 citations). Surgical resection remains the standard treatment, with recurrence linked to Carney complex (Carney et al., 1985; 1114 citations). Over 40 years, 112 left atrial myxoma cases showed obstruction symptoms in 47% (Pinède et al., 2001; 849 citations).
Why It Matters
Timely diagnosis of cardiac myxomas prevents embolic strokes and sudden cardiac death, as these tumors embolize in up to 40% of cases (Reynen, 1995). Association with Carney complex enables genetic screening for familial recurrence, impacting endocrine and cutaneous tumor surveillance (Kirschner et al., 2000; 1130 citations; Stratakis et al., 2001; 771 citations). Surgical management protocols from large series guide echocardiography and resection techniques, reducing operative mortality to under 5% (Pinède et al., 2001; Butany et al., 2005). Radiologic-pathologic correlation aids preoperative planning (Grebenc et al., 2000; 589 citations).
Key Research Challenges
Distinguishing from thrombi
Echocardiography often confuses myxomas with thrombi due to similar mobility and left atrial location. Histopathology confirms myxomas via stellate cells and myxoid stroma, but preoperative differentiation remains imprecise (Reynen, 1995). Advanced imaging like cardiac MRI improves specificity but lacks standardization (Grebenc et al., 2000).
Carney complex detection
Up to 50% of recurrent myxomas link to Carney complex, requiring PRKAR1A gene testing. Clinical criteria miss subclinical cases, delaying family screening (Kirschner et al., 2000). Stratakis et al. (2001) outline diagnostic recommendations, yet endocrine overactivity screening varies.
Recurrence risk prediction
Recurrence rates reach 13% post-resection, higher in Carney complex patients (Carney et al., 1985). No validated histopathological or molecular predictors exist beyond incomplete excision (Pinède et al., 2001). Long-term surveillance protocols need refinement.
Essential Papers
Cardiac Myxomas
K Reynen · 1995 · New England Journal of Medicine · 1.1K citations
Although cardiac myxomas are histologically benign, they may be lethal because of their strategic position. They can mimic not only every cardiac disease but also infective, immunologic, and malign...
Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex
Lawrence S. Kirschner, J. Aidan Carney, Svetlana Pack et al. · 2000 · Nature Genetics · 1.1K citations
The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
J. Aidan Carney, Hymie Gordon, Paul C. Carpenter et al. · 1985 · Medicine · 1.1K citations
Of 40 patients (16 males and 24 females), 29 had cardiac myxoma(s), 14 had skin pigmentation (lentigo and several types of nevi) which also commonly affected the lips, 6 had skin myxoma(s), and 12 ...
Clinical Presentation of Left Atrial Cardiac Myxoma
L. Pinède, P. Duhaut, R Loire · 2001 · Medicine · 849 citations
We analyzed a series of 112 consecutive cases of left atrial myxoma diagnosed in a single French hospital (72 women and 40 men; age range, 5-84 yr) over 40 years, from 1959 to 1998. Symptoms of mit...
Cardiac tumours: diagnosis and management
Jagdish Butany, Vidhya Nair, Ather Naseemuddin et al. · 2005 · The Lancet Oncology · 810 citations
Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies.
Alfred K. Lam, Paul Dickens, A. C. L. Chan · 1993 · PubMed · 777 citations
Cardiac involvement by primary and secondary tumors is one of the least investigated subjects in oncology. Seven cases of primary and 154 cases of secondary cardiac tumors from autopsies performed ...
Clinical and Molecular Features of the Carney Complex: Diagnostic Criteria and Recommendations for Patient Evaluation
Constantine A. Stratakis, Lawrence S. Kirschner, J. Aidan Carney · 2001 · The Journal of Clinical Endocrinology & Metabolism · 771 citations
Carney complex is a multiple neoplasia syndrome featuring cardiac, endocrine, cutaneous, and neural tumors, as well as a variety of pigmented lesions of the skin and mucosae. Carney complex is inhe...
Reading Guide
Foundational Papers
Start with Reynen (1995) for clinical overview (1139 citations), then Carney et al. (1985) for syndrome description (1114 citations), followed by Pinède et al. (2001) for 112-case presentation data (849 citations).
Recent Advances
Kirschner et al. (2000) on PRKAR1A mutations (1130 citations); Stratakis et al. (2001) diagnostic criteria (771 citations); Butany et al. (2005) management (810 citations).
Core Methods
Echocardiography for detection; cardiac MRI for characterization (Grebenc et al., 2000); surgical resection with histopathological confirmation; PRKAR1A sequencing for Carney complex.
How PapersFlow Helps You Research Cardiac Myxomas
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 1,139-citing Reynen (1995) 'Cardiac Myxomas' to Carney complex genetics via Kirschner et al. (2000), revealing 1,130-citation clusters. exaSearch uncovers histopathological differentials from Grebenc et al. (2000), while findSimilarPapers links Butany et al. (2005) to surgical outcomes.
Analyze & Verify
Analysis Agent employs readPaperContent on Pinède et al. (2001) to extract 112-case demographics and symptoms, verified via verifyResponse (CoVe) against Reynen (1995) for embolization rates. runPythonAnalysis computes recurrence statistics from Carney et al. (1985) data using pandas, with GRADE grading assigning high evidence to surgical cohorts (Butany et al., 2005).
Synthesize & Write
Synthesis Agent detects gaps in recurrence predictors across Stratakis et al. (2001) and Pinède et al. (2001), flagging Carney complex underdiagnosis. Writing Agent uses latexEditText and latexSyncCitations to draft review sections citing 10 papers, with latexCompile generating PDF and exportMermaid visualizing myxoma-pathway diagrams.
Use Cases
"Analyze recurrence rates in Carney complex myxomas from provided papers"
Research Agent → searchPapers('Carney complex myxoma recurrence') → Analysis Agent → runPythonAnalysis(pandas on Carney 1985 + Stratakis 2001 data) → CSV export of 13% rate stats with confidence intervals.
"Draft LaTeX review on left atrial myxoma presentation"
Synthesis Agent → gap detection (Pinède 2001 vs Reynen 1995) → Writing Agent → latexEditText('symptom triad') → latexSyncCitations(5 papers) → latexCompile → formatted PDF with figure captions.
"Find code for myxoma embolization risk models"
Research Agent → paperExtractUrls(Butany 2005) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for logistic regression on 112-case Pinède dataset.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ myxoma papers via citationGraph from Reynen (1995), producing structured report on embolization risks with GRADE scores. DeepScan applies 7-step CoVe to verify Carney complex criteria from Kirschner (2000) against Stratakis (2001). Theorizer generates hypotheses on PRKAR1A mutation-tumor links from genetic abstracts.
Frequently Asked Questions
What defines a cardiac myxoma?
Cardiac myxomas are benign tumors, mostly in the left atrium, composed of stellate cells in myxoid stroma, causing obstruction or embolization (Reynen, 1995).
What are key diagnostic methods?
Echocardiography detects 95% of myxomas; MRI differentiates from thrombi via heterogeneous signal (Grebenc et al., 2000). Histopathology confirms post-resection.
What are seminal papers?
Reynen (1995; 1139 citations) reviews clinical features; Carney et al. (1985; 1114 citations) defines Carney complex; Pinède et al. (2001; 849 citations) analyzes 112 cases.
What open problems exist?
Predicting recurrence without genetic testing; standardizing imaging for thrombus differentiation; long-term outcomes in Carney complex families.
Research Cardiac tumors and thrombi with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cardiac Myxomas with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cardiac tumors and thrombi Research Guide